Group One Trading
DNLI icon

Group One Trading’s Denali Therapeutics DNLI Stock Holding History

Group One Trading’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Sell
900
-4,700
-84% -$96.6K ﹤0.01% 5918
2026
Q1 		$108K Buy
5,600
+5,500
+5,500% +$109K ﹤0.01% 4654
2025
Q4 		$1.65K Hold
100
– – ﹤0.01% 7608
2025
Q3 		$1.45K Buy
+100
New +$1.44K ﹤0.01% 7987
2024
Q4 		– Sell
-1,900
Closed -$55.3K – 7415
2024
Q3 		$55.3K Buy
1,900
+300
+19% +$7.44K ﹤0.01% 4599
2024
Q2 		$37.2K Buy
1,600
+1,100
+220% +$21.1K ﹤0.01% 4752
2024
Q1 		$10.3K Buy
+500
New +$9.4K ﹤0.01% 5847
2023
Q4 		– Sell
-200
Closed -$4.13K – 7552
2023
Q3 		$4.13K Sell
200
-400
-67% -$10.1K ﹤0.01% 6791
2023
Q2 		$17.7K Sell
600
-78,000
-99% -$2.19M ﹤0.01% 6063
2023
Q1 		$1.81M Buy
+78,600
New +$2.16M 0.01% 1616
2022
Q3 		– Sell
-1,300
Closed -$38K – 7662
2022
Q2 		$38K Sell
1,300
-4,900
-79% -$128K ﹤0.01% 5788
2022
Q1 		$199K Sell
6,200
-18,500
-75% -$637K ﹤0.01% 4806
2021
Q4 		$1.1M Buy
+24,700
New +$1.17M ﹤0.01% 3262
2021
Q3 		– Sell
-300
Closed -$24K – 8285
2021
Q2 		$24K Buy
+300
New +$18.6K ﹤0.01% 7072
2021
Q1 		– Sell
-500
Closed -$42K – 7658
2020
Q4 		$42K Sell
500
-700
-58% -$42.3K ﹤0.01% 5119
2020
Q3 		$43K Buy
1,200
+1,100
+1,100% +$33.1K ﹤0.01% 4727
2020
Q2 		$2K Buy
+100
New +$2.35K ﹤0.01% 5546
2019
Q4 		– Sell
-1,100
Closed -$17K – 5198
2019
Q3 		$17K Buy
+1,100
New +$21K ﹤0.01% 4399
2019
Q2 		– Sell
-100
Closed -$2K – 5033
2019
Q1 		$2K Hold
100
– – ﹤0.01% 4580
2018
Q4 		$2K Buy
+100
New +$1.81K ﹤0.01% 4650

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's DNLI Position: Q2 2026 in Review

Group One Trading opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 776 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #6025 among its holdings. This is a return to the name: Group One Trading previously reported a position in DNLI as recently as Q3 2024.

Group One Trading first reported a position in DNLI in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.15M in Q1 2023. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Group One Trading held 776 shares of Denali Therapeutics worth $20K as of Q2 2026.
  • Denali Therapeutics was a new Group One Trading position in Q2 2026.
  • Denali Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6025 holding.
  • Group One Trading first reported a position in Denali Therapeutics in Q4 2018 and has held it in 11 quarters since.
  • Group One Trading's Denali Therapeutics position peaked at $1.15M in Q1 2023.
  • 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.